PROFITABLE DNA NUTRITION PLATFORM, 10,000 USERS, 59% SDE MARGIN

Listing Number: 60091-904075

Listing Details

PROFITABLE DNA NUTRITION PLATFORM, 10,000 USERS, 59% SDE MARGIN
Price: $1,199,000
Location: Wyoming
  • Down Payment: $1,199,000
  • Sales: $546,313
  • Seller's Discretionary Earnings: $318,521
  • Inventory: $4,000
  • Furniture, Fixtures, and Equipment: $0
  • Employees: 0
  • Year Established: 2018
  • Reason for Selling: Other Personal Interests

Interested in learning more about this business?

Fill out the form below to gain access to additional information.

Privacy Policy

We are committed to safeguarding the privacy of our website visitors and service users. By checking the opt-in box, you agree to Transworld Business Advisors' Privacy Policy and allow business use of your provided data. Message and Data Rates may apply. Message frequency may vary. You can STOP messaging by sending STOP and get more help by sending HELP. Our full privacy policy can be found here: www.tworld.com/trust

For More Information About This Listing
Tony Keane
License # RE-16610
President's Club

Business Description

A profitable, founder-built precision-nutrition platform that has sold its core product every day for eight years.
 
The company translates a customer's DNA into a practical, personalized way of eating. A proprietary algorithm classifies each customer into one of twenty named diet types, then generates a personalized meal plan and nutrition protocol built around how that individual actually metabolizes fat, carbohydrate, protein, caffeine, histamine, and dietary cholesterol. On top of that core sits a growing library of premium health reports — cardiovascular, methylation, micronutrient, longevity, sleep, and more — sold as an annual membership currently held by approximately 1,000 members, plus a branded supplement line matched to the genetic results.
 
This is a product with demonstrated durable product-market fit. It launched in 2018, has served thousands of customers, and has generated revenue continuously since. The twenty-diet-type framework is what customers connect with, talk about, and return for: an identity and a plan rather than a raw data dump. Customer acquisition runs on SEO, organic search, email, and word of mouth, supported by HSA/FSA eligibility and inbound demand from clinics and integrative-medicine practitioners.
 
The business is profitable and capital efficient. Revenue grew from under $60,000 to $555,300 in three years while remaining profitable every year. In 2025 it generated $327,200 in seller's discretionary earnings — a 59% SDE margin — on a fully remote operation with no full-time employees and approximately 79% gross margins.
 
The platform has also proven it can extend. A 2025 supplement line and a 2026 environmental-genomics release were both built and shipped on modest budgets using the existing architecture, and a consented research cohort has been accumulating alongside the core business. These represent optionality on top of a proven cash-generating core.
 
Highlights:

  • $555,300 revenue in 2025 | $327,200 SDE | ~79% gross margins
  • Eight consecutive years of sales on the core DNA nutrition product, launched 2018
  • ~110% three-year revenue CAGR (FY22 $58.5K → FY25 $555.3K); SDE up from $29.9K to $327.2K
  • Proprietary twenty-diet-type taxonomy built on 200+ vetted genetic factors, each carrying an internal Science Grade derived from a two-year peer-reviewed literature review
  • AI engine generating personalized meal plans and nutrition protocols directly from genetic results
  • Approximately 1,000 members paying annual fees — an established subscription layer built without a dedicated conversion program
  • Two acquisition paths into the core product: physical test kits fulfilled through a CLIA-certified lab, and near-zero-COGS analysis of raw data uploaded from 23andMe and Ancestry
  • 2025 supplement line with repeat-purchase behavior
  • Demonstrated B2B demand from wellness clinics, IV clinics, functional-medicine providers, and physicians
  • Strong SEO, low CAC, HSA/FSA eligible
  • Lean and remote: owner part-time plus four independent contractors, no physical overhead
  • Consented, transferable genome + environment research dataset — a monetization path not yet activated